Coloplast A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0060448595
DKK
581.20
433.64 (293.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Coloplast A/S stock-summary
stock-summary
Coloplast A/S
Pharmaceuticals & Biotechnology
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Company Coordinates stock-summary
Company Details
Holtedam 1-3 , HUMLEBAEK None : 3050
stock-summary
Tel: 45 4911111145 4911 3376
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Lars Rasmussen
Chairman of the Board
Mr. Niels Louis-Hansen
Deputy Chairman of the Board
Mr. Thomas Barfod
Director, Employee Representative
Mr. Nikolaj Kyhe Gundersen
Director, Employee Representative
Mr. Joergen Tang-Jensen
Director
Mr. Roland Vendelbo Pedersen
Director, Employee Representative
Mr. Carsten Hellmann
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
6,958 Million
(Quarterly Results - Jun 2025)
Net Profit:
805 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

DKK 121,369 Million ()

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.64%

stock-summary
Debt Equity

1.04

stock-summary
Return on Equity

24.43%

stock-summary
Price to Book

7.53